FP7
NILVAD
A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 66 months
- Total cost
- EUR 7,916,016
- EU contribution
- EUR 5,999,978
- Participants
- 17 from 11 countries
- Topic
- FP7_HEALTH.2011.2.2.2-1
- Grant agreement
- 279093
Coordinated by The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin (IEIreland).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin | IEIreland | Coordinator | EUR 986,381 | PIC (1.00) |
| Gabo:mi Gesellschaft Fur Ablauforganisation:milliarium Mbh & Co KG | DEGermany | Participant | EUR 220,481 | PIC (1.00) |
| Universitaet Ulm | DEGermany | Participant | EUR 92,040 | PIC (1.00) |
| Centre Hospitalier Regional et Universitaire de Lille | FRFrance | Participant | EUR 427,635 | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 855,563 | known name (0.95) |
| Aristotelio Panepistimio Thessalonikis | GRGreece | Participant | EUR 511,202 | PIC (1.00) |
| Szegedi Tudomanyegyetem | HUHungary | Participant | EUR 87,540 | known name (0.95) |
| Bord Ospideil Naoimh Sheamuis | IEIreland | Participant | EUR 1,105,243 | PIC (1.00) |
| E-Search Limited | IEIreland | Participant | EUR 114,400 | PIC (1.00) |
| Mmi Clinical Research Development Ireland | IEIreland | Participant | EUR 24,750 | PIC (1.00) |
| University College Cork - National University of Ireland, Cork | IEIreland | Participant | EUR 231,390 | VAT number (0.97) |
| University College Dublin, National University of Ireland, Dublin | IEIreland | Participant | EUR 122,696 | VAT number (0.97) |
| Istituto di Ricerche Farmacologiche Mario Negri | ITItaly | Participant | EUR 352,709 | PIC (1.00) |
| Alzheimer Europe | LULuxembourg | Participant | EUR 33,599 | PIC (1.00) |
| Stichting Radboud Universiteit | NLNetherlands | Participant | EUR 539,811 | known name (0.95) |
| Goeteborgs Universitet | SESweden | Participant | EUR 159,360 | PIC (1.00) |
| Archer Pharmaceuticals Inc Corp | USUnited States | Participant | EUR 135,178 | PIC (1.00) |
Changes of the consortium
First seen on with 17 participants from 11 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.